Structure |
Chemical Name |
CAS |
MF |
![Lenvatinib Impurity 2](/CAS/20200611/GIF/2380197-90-8.gif) |
Lenvatinib Impurity 2 |
2380197-90-8 |
C28H22ClN5O5 |
![FeBuxostat Impurity 33](/CAS/20180808/GIF/100118-38-5.gif) |
FeBuxostat Impurity 33 |
100118-38-5 |
C12H14O5 |
![(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl)](/CAS/20210111/GIF/1642630-12-3.gif) |
(S)-3-(4-phenoxyphenyl)-1-(piperidin-3-yl) |
1642630-12-3 |
C22H22N6O |
![Latamoxef Impurity 1](/CAS/20210111/GIF/75007-70-4.gif) |
Latamoxef Impurity 1 |
75007-70-4 |
C19H20N6O7S |
![Amlodipine iMpurity K](/CAS/20180527/GIF/1809326-44-0.gif) |
Amlodipine iMpurity K |
1809326-44-0 |
C18H21ClN2O5 |
![Cabozantinib impurity 4](/CAS/20210111/GIF/95932-39-1.gif) |
Cabozantinib impurity 4 |
95932-39-1 |
C11H15NO3 |
![Rosuvastatin EP Impurity C](/CAS/20211123/GIF/1620823-61-1.gif) |
Rosuvastatin EP Impurity C |
1620823-61-1 |
C22H27FN3NaO6S |
![6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine](/CAS/20180527/GIF/1145671-52-8.gif) |
6,7-bis(2-methoxyethoxy)-N-phenylquinazolin-4-amine |
1145671-52-8 |
C20H23N3O4 |
![(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate](/CAS/20180527/GIF/1052063-36-1.gif) |
(3R,4R,5S)-ethyl 4-acetamido-5-amino-3-isopropoxycyclohex-1-enecarboxylate |
1052063-36-1 |
C14H24N2O4 |
![4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate](/CAS/20180527/GIF/941296-96-4.gif) |
4-(N-(tert-butyl)acetamido)-5-(diallylamino)-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate |
941296-96-4 |
C16H28N2O4 |
![(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid](/CAS/20180629/GIF/CB13159054.gif) |
(2R,5S)-5-(4-amino-5-fluoro-2-oxopyrimidin-1(2H)-yl)-1,3-oxathiolane-2-carboxylic acid |
|
C8H8FN3O4S |
![Amlodipine Impurity 10](/CAS/20180629/GIF/CB13159160.gif) |
Amlodipine Impurity 10 |
2170104-51-3 |
C26H31ClN2O8S |
![Clopidogrel Impurity 8](/CAS/20180629/GIF/CB13159236.gif) |
Clopidogrel Impurity 8 |
|
C15H14ClNO2S |
![Nilotinib genotoxic impurity 3](/CAS/20200611/GIF/915711-42-1.gif) |
Nilotinib genotoxic impurity 3 |
915711-42-1 |
C19H17F3N4O |
![Dapagliflozin Open Ring](/CAS/20200611/GIF/2100872-88-4.gif) |
Dapagliflozin Open Ring |
2100872-88-4 |
C21H27ClO7 |
![Rortezide impurity](/) |
Rortezide impurity |
|
|
![Cabozantinib Impurity A](/) |
Cabozantinib Impurity A |
|
|
![Loxoprofen Impurity E](/) |
Loxoprofen Impurity E |
|
|
![(R)-4-Propylpyrrolidin-2-one](/CAS/20180527/GIF/930123-37-8.gif) |
(R)-4-Propylpyrrolidin-2-one |
930123-37-8 |
C7H13NO |
![Rocuronium Bromide Intermediate B Impurity E-1](/CAS/20180808/GIF/1190105-60-2.gif) |
Rocuronium Bromide Intermediate B Impurity E-1 |
1190105-60-2 |
C29H48N2O3 |
![4-Chloro-2-propylsulfanyl-pyrimidine](/CAS/20180527/GIF/1351990-36-7.gif) |
4-Chloro-2-propylsulfanyl-pyrimidine |
1351990-36-7 |
C7H9ClN2S |
![benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate](/CAS/20200611/GIF/1194550-67-8.gif) |
benzyl (S)-2-(2-(benzofuran-6-carbonyl)-5,7-dichloro-1,2,3,4-tetrahydroisoquinoline-6-carboxamido)-3-(3-(methylsulfonyl)phenyl)propanoate |
1194550-67-8 |
C36H30Cl2N2O7S |
![D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-](/CAS/20180528/GIF/119238-52-7.gif) |
D-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]- |
119238-52-7 |
C9H15NO3S |
![2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI)](/CAS/20200119/GIF/145281-92-1.gif) |
2,4(1H,3H)-Pyrimidinedione,5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]-, (2S-cis)- (9CI) |
145281-92-1 |
C8H9FN2O4S |
![Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]-](/CAS/20180529/GIF/15026-80-9.gif) |
Cyclopentanecarboxylic acid, 1-[(1-oxopentyl)amino]- |
15026-80-9 |
C11H19NO3 |
![L-Phenylalanine, N-L-leucyl-, methyl ester](/CAS/20180529/GIF/38155-18-9.gif) |
L-Phenylalanine, N-L-leucyl-, methyl ester |
38155-18-9 |
C16H24N2O3 |
![Ethanol, 2-[(2-chloroethyl)amino]-](/CAS/20180529/GIF/3890-98-0.gif) |
Ethanol, 2-[(2-chloroethyl)amino]- |
3890-98-0 |
C4H10ClNO |
![Anthranilic acid, N-furfuryl-5-sulfamoyl-](/CAS/20180531/GIF/4818-85-3.gif) |
Anthranilic acid, N-furfuryl-5-sulfamoyl- |
4818-85-3 |
C12H12N2O5S |
![1,3-Benzodioxol-4-ol](/CAS/20180531/GIF/69393-72-2.gif) |
1,3-Benzodioxol-4-ol |
69393-72-2 |
C7H6O3 |
![1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)-](/CAS/20180527/GIF/774582-60-4.gif) |
1H-Benzimidazole, 6-bromo-2-methyl-4-(phenylmethoxy)- |
774582-60-4 |
C15H13BrN2O |
![2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide](/CAS/20180527/GIF/857570-37-7.gif) |
2-Diethylamino-N-(2,5-dimethyl-phenyl)-acetamide |
857570-37-7 |
C14H22N2O |
![(R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE](/CAS/GIF/216854-24-9.gif) |
(R)-1-BENZYL-3-N-BOC-AMINOPIPERIDINE |
216854-24-9 |
C17H26N2O2 |
![(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/CAS/20180527/GIF/1987887-92-2.gif) |
(Z)-methyl 3-(((4-(methylamino)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
1987887-92-2 |
C24H21N3O3 |
![1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one](/CAS/20180527/GIF/1971858-36-2.gif) |
1-(prop-1-en-2-yl)-3-(2-(4-(3-(trifluoromethyl)phenyl)piperazin-1-yl)ethyl)-1H-benzo[d]imidazol-2(3H)-one |
1971858-36-2 |
C23H25F3N4O |
![2-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol](/CAS/20180527/GIF/1033803-59-6.gif) |
2-(3-(methylamino)-1-(thiophen-2-yl)propyl)naphthalen-1-ol |
1033803-59-6 |
C18H19NOS |
![Bendamustine Desmethyl Impurity](/CAS/20180906/GIF/41515-13-3.gif) |
Bendamustine Desmethyl Impurity |
41515-13-3 |
C15H19Cl2N3O2 |
![(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine](/CAS/20180527/GIF/878757-08-5.gif) |
(R)-N,N-dimethyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine |
878757-08-5 |
C19H21NOS |
![Capecitabine Impurity 10](/) |
Capecitabine Impurity 10 |
|
|
![Carfilzomib Impurity C](/) |
Carfilzomib Impurity C |
|
|
![Cefathiamidine Impurity 4](/CAS/20210111/GIF/1418224-75-5.gif) |
Cefathiamidine Impurity 4 |
1418224-75-5 |
C10H11BrN2O5S |
![Cefodizime Impurity 2](/) |
Cefodizime Impurity 2 |
|
|
![Choline Fenofibrate Impurity 1](/CAS/20180527/GIF/2985-79-7.gif) |
Choline Fenofibrate Impurity 1 |
2985-79-7 |
C13H9ClO2 |
![DecitaBine Impurity 11](/) |
DecitaBine Impurity 11 |
|
|
![Isavuconazole Impurity 21](/) |
Isavuconazole Impurity 21 |
|
|
![Isavuconazole Impurity 27](/) |
Isavuconazole Impurity 27 |
|
|
![Istradefylline Impurity E](/) |
Istradefylline Impurity E |
|
|
![Linagliptin Impurity 41](/) |
Linagliptin Impurity 41 |
|
|
![PalBociclib Impurity 17](/) |
PalBociclib Impurity 17 |
|
|
![PalBociclib Impurity 24](/) |
PalBociclib Impurity 24 |
|
|
![Posaconazole Impurity 12](/) |
Posaconazole Impurity 12 |
|
|
![Posaconazole Impurity 24](/CAS/20211123/GIF/165115-78-6.gif) |
Posaconazole Impurity 24 |
165115-78-6 |
C19H20F2O2 |
![Sitagliptin Impurity 24](/CAS/20210111/GIF/2349567-54-8.gif) |
Sitagliptin Impurity 24 |
2349567-54-8 |
C15H19F2NO4 |
![Tamoxifen EP Impurity H](/CAS/20180527/GIF/809285-09-4.gif) |
Tamoxifen EP Impurity H |
809285-09-4 |
C43H48N2O2 |
![Tenofovir impurity Q](/) |
Tenofovir impurity Q |
|
|
![Trelagliptin Impurity 20](/CAS/20210111/GIF/1821520-42-6.gif) |
Trelagliptin Impurity 20 |
1821520-42-6 |
C20H22FN5O3 |
![Umeclidinium Impurity 3](/CAS/20211123/GIF/869113-45-1.gif) |
Umeclidinium Impurity 3 |
869113-45-1 |
C29H32BrNO3 |
![Vardenafil Impurity 7](/CAS/20200611/GIF/448184-56-3.gif) |
Vardenafil Impurity 7 |
448184-56-3 |
C21H26N6O7S |
![Moxifloxacin Related Compound A (HCl salt form)](/CAS/20211123/GIF/151282-23-4.gif) |
Moxifloxacin Related Compound A (HCl salt form) |
151282-23-4 |
C20H22ClF2N3O3 |
![8-Hydroxy Entecavir](/CAS/20210111/GIF/1795791-10-4.gif) |
8-Hydroxy Entecavir |
1795791-10-4 |
C12H15N5O4 |
![1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)-](/CAS/20180527/GIF/1404559-22-3.gif) |
1-Pyrrolidinecarboxylic acid, 4-[4-(3-methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-(3-thiazolidinylcarbonyl)-, 1,1-dimethylethyl ester, (2S,4R)- |
1404559-22-3 |
C27H38N6O3S |
![Ampicillin Impurity A](/) |
Ampicillin Impurity A |
|
|
![Oxacillin Sodium Impurity B(EP)](/) |
Oxacillin Sodium Impurity B(EP) |
|
|
![3,5-dichlorothiophene-2-carboxylic acid](/CAS/20180527/GIF/89166-94-9.gif) |
3,5-dichlorothiophene-2-carboxylic acid |
89166-94-9 |
C5H2Cl2O2S |
![Brexpiprazole Impurity 2](/CAS/20200611/GIF/2094559-58-5.gif) |
Brexpiprazole Impurity 2 |
2094559-58-5 |
C38H40N4O4S |
![2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid](/CAS/20180527/GIF/80047-38-7.gif) |
2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carboxylic acid |
80047-38-7 |
C12H10N2O3 |
![Levofloxacin Impurity 7](/CAS/20180527/GIF/1607796-83-7.gif) |
Levofloxacin Impurity 7 |
1607796-83-7 |
C15H14FNO5 |
![Moxifloxacin EP Impurity E HCl](/) |
Moxifloxacin EP Impurity E HCl |
|
|
![Pantoprazole Impurity 11](/CAS/20180906/GIF/172282-50-7.gif) |
Pantoprazole Impurity 11 |
172282-50-7 |
C7H8F2N2O |
![Solifenacin Related Compound 24](/CAS/20180808/GIF/1682642-69-8.gif) |
Solifenacin Related Compound 24 |
1682642-69-8 |
C15H23ClN2 |
![Ticagrelor Related Compound 44](/CAS/20200611/GIF/1431867-40-1.gif) |
Ticagrelor Related Compound 44 |
1431867-40-1 |
C8H12ClN3OS |
![(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide](/CAS/20180527/GIF/1006614-51-2.gif) |
(trans)-2-(3,4-difluorophenyl)cyclopropanecarboxamide |
1006614-51-2 |
C10H9F2NO |
![2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride](/CAS/20180629/GIF/CB13382168.gif) |
2-cyano-N-methyl-N-((3R,4R)-4-methyl piperidin-3-yl) Acetamide hydrochloride |
1640971-87-4 |
C10H18ClN3O |
![6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine](/CAS/20180629/GIF/CB13382315.gif) |
6-methyl-N1-(4-methyl-6-(pyridin-3-yl)pyrimidin-2-yl)benzene-1,3-diamine |
|
C17H17N5 |
![WPDCFRNNHUYQGW-IUXPMGMMSA-N](/CAS/20211123/GIF/1628639-06-4.gif) |
WPDCFRNNHUYQGW-IUXPMGMMSA-N |
1628639-06-4 |
C21H23NO4 |
![tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate](/CAS/20200611/GIF/521974-00-5.gif) |
tert-Butyl 2-((4S,6S)-6-(chloromethyl(02,2-1,3-dioxan-4-yl)acetate |
521974-00-5 |
C13H23ClO4 |
![Cefadroxil Sulfoxide](/CAS/20180808/GIF/182290-77-3.gif) |
Cefadroxil Sulfoxide |
182290-77-3 |
C16H17N3O6S |
![GSFIWDGFHNAUFU-UHFFFAOYSA-N](/CAS/20211123/GIF/2125702-80-7.gif) |
GSFIWDGFHNAUFU-UHFFFAOYSA-N |
2125702-80-7 |
C16H29N5O4 |
![2,5-dichloro-N,N-dimethylbenzamide](/CAS/20180528/GIF/90526-01-5.gif) |
2,5-dichloro-N,N-dimethylbenzamide |
90526-01-5 |
C9H9Cl2NO |
![Ibrutinib Impurity 9](/CAS/20180527/GIF/2068022-09-1.gif) |
Ibrutinib Impurity 9 |
2068022-09-1 |
C25H21D5N6O4 |
![4-Chlor-3-hydroxybutyronitril](/CAS/GIF/105-33-9.gif) |
4-Chlor-3-hydroxybutyronitril |
105-33-9 |
C4H6ClNO |
![(Z)-2-propylhept-2-enal](/CAS/20180529/GIF/95667-14-4.gif) |
(Z)-2-propylhept-2-enal |
95667-14-4 |
C10H18O |
![(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL](/CAS/20180529/GIF/1335470-16-0.gif) |
(R)-3-AMINO-4-(2,4-DIFLUOROPHENYL)-BUTYRIC ACID-HCL |
1335470-16-0 |
C10H11F2NO2 |
![4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl](/CAS/20180629/GIF/CB13955982.gif) |
4,4'-dichloro-3,3'-bis(4-ethoxybenzyl)-1,1'-biphenyl |
2176485-21-3 |
C30H28Cl2O2 |
![N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide](/CAS/20180629/GIF/294852-91-8.gif) |
N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide |
294852-91-8 |
C18H22N2O |
![N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine](/CAS/20180629/GIF/1052691-22-1.gif) |
N6-propyl-3a,4,5,6,7,7a-hexahydrobenzo[d]thiazole-2,6-diamine |
1052691-22-1 |
C10H19N3S |
![3-pentylisoindolin-1-one](/CAS/20180629/GIF/691863-84-0.gif) |
3-pentylisoindolin-1-one |
691863-84-0 |
C13H17NO |
![(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate](/CAS/20180629/GIF/1598416-05-7.gif) |
(1R,3R)-2-acetyl-1-(benzo[d][1,3]dioxol-5-yl)-2,3,4,9-tetrahydro- 1H-pyrido[3,4-b]indole-3-carboxylate |
1598416-05-7 |
C22H20N2O5 |
![1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride](/CAS/20180702/GIF/CB14033522.gif) |
1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N- ((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl) methyl)-N-methylmethanamine hydrochloride |
|
C33H28ClF2N5O4S2 |
![Labetalol EP impurity D](/CAS/20211123/GIF/32780-65-7.gif) |
Labetalol EP impurity D |
32780-65-7 |
C9H13ClN2O3 |
![ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20180702/GIF/625115-53-9.gif) |
ethyl (4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b] pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-53-9 |
C21H21FN8O2 |
![2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID](/CAS/GIF/60091-87-4.gif) |
2-[(4-CHLORO-2-NITROPHENYL)AMINO]-BENZOIC ACID |
60091-87-4 |
C13H9ClN2O4 |
![Fulvestrant impurity I](/) |
Fulvestrant impurity I |
|
|
![Emtricitabine](/CAS/20210111/GIF/61548-81-0.gif) |
Emtricitabine |
61548-81-0 |
C11H22O3S |
![tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate](/CAS/20180713/GIF/608142-93-4.gif) |
tert-butyl 4-(3-nitropyridin-4-yl)piperazine-1-carboxylate |
608142-93-4 |
C14H20N4O4 |
![4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE](/CAS/GIF/29489-04-1.gif) |
4-BROMO-1-(TOLUENE-4-SULFONYL)-1,2,3,4-TETRAHYDROBENZO[B]AZEPIN-5-ONE |
29489-04-1 |
C17H16BrNO3S |
![FEXOFENADINE, METHYL ESTER](/StructureFile/ChemBookStructure9/GIF/CB1457294.gif) |
FEXOFENADINE, METHYL ESTER |
154825-96-4 |
C33H41NO4 |
![Bendamustine Related Impurity 21](/) |
Bendamustine Related Impurity 21 |
|
|
![Bendamustine Related Impurity 8](/) |
Bendamustine Related Impurity 8 |
|
|
![Bortezomib Impurity 33](/) |
Bortezomib Impurity 33 |
|
|
![Moxifloxacin Impurity 31](/) |
Moxifloxacin Impurity 31 |
|
|